about
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-cau...
Read More
8.11
0.08
(1.00%)
274.2K
XNAS Volume
XNAS 17 Jul, 2026 2:05 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Arvinas Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..